PharVision Advisers’s NewMarket NEU Stock Holding History

PharVision Advisers’s Portfolio NEU Stock Details NEU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-248	Closed	-$205K	–	901
2025 Q3	$205K	Buy	+248	New	+$191K	0.12%	496

Other funds holding NEU

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PharVision Advisers's NEU Position: Q4 2025 in Review

PharVision Advisers sold out of NewMarket (NEU) in Q4 2025, closing a stake of 248 shares — an estimated $205K sold.

PharVision Advisers first reported a position in NEU in Q3 2025 and held it in 1 quarter. The position peaked at $205K in Q3 2025. 414 funds tracked by Wall St. Rank hold NEU as of Q4 2025.

PharVision Advisers reported no remaining NewMarket position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 248 NewMarket shares in Q4 2025, an estimated $205K.
PharVision Advisers first reported a position in NewMarket in Q3 2025 and held it in 1 quarter.
PharVision Advisers's NewMarket position peaked at $205K in Q3 2025.
414 funds tracked by Wall St. Rank held NewMarket as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.